We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Marina Biotech Announces Patent Allowance for its Proprietary Nucleic Acid Delivery Technology

Product News   Apr 13, 2011

 
Marina Biotech Announces Patent Allowance for its Proprietary Nucleic Acid Delivery Technology
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Product News

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

READ MORE

Vaccine Against COVID-19 Advances to Late-stage Development

Product News

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against COVID-19.

READ MORE

GSK and Clover Biopharmaceuticals COVID-19 Vaccine Begins Human Clinical Trials

Product News

GSK’s scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered into human clinical trials.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE